.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Accenture
UBS
AstraZeneca
Farmers Insurance
Teva
US Department of Justice
Cipla
Julphar
McKinsey

Generated: June 23, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: dactinomycin

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Recordati Rare
COSMEGEN
dactinomycin
INJECTABLE;INJECTION050682NDARECORDATI RARE DISEASES, INC.55292-811-5512 VIAL, SINGLE-DOSE in 1 CARTON (55292-811-55) > 1 mL in 1 VIAL, SINGLE-DOSE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
UBS
Cerilliant
Chinese Patent Office
Fish and Richardson
Farmers Insurance
Covington
Novartis
Accenture
Chubb

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot